News

Under the collaboration, FivePrime will screen its comprehensive protein library in both cell-based assays and primary in vivo screens directed toward finding potential therapeutic protein products and antibody

The study results included data from a 464-patient randomized, double-blind, four-week, Phase IIb study that evaluated both the efficacy and tolerability of once-daily aclidinium (25mcg, 50mcg, 100mcg, 200mcg

The study will focus on men who have been referred to urologist and subsequently have been selected for a prostate biopsy, but will be restricted to men who

This Phase II study is a multi-center, randomized, double-blind, controlled study in patients with complicated skin and skin structure infections (cSSSI) presumed to be caused by gram-positive pathogens.

Richard Domanik, president and COO of CytoCore, said: “QuantRx will be our exclusive manufacturer for this product, which allows us to introduce a new paradigm in cytology sample

The study is placebo-controlled and double-blinded, and will include up to five cohorts receiving escalating doses. As many as 35 subjects will be included, with six active subjects

According to the company, the products are advanced wound care dressings that create a moist wound healing environment, deactivate harmful wound proteases and promote tissue growth in chronic

The European Federation of Pharmaceutical Industries and Associations (EFPIA)believes that a ban on repackaging will help deter the counterfeiters from entering the legitimate supply chain. The EFPIA also

The study, called Stealth C-2, is the second in a series of clinical trials designed to evaluate the safety and efficacy of nitazoxanide tablets in combination with Pegasys